A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women.
Paula Basso LimaJoana Alexandria Ferreira DiasDaniel Pinho CassianoAna Cláudia Cavalcante EspositoEdiléia BagatinLuciane Donida Bartoli MiotHélio Amarante MiotPublished in: International journal of dermatology (2020)
Cysteamine proved to be safe, well-tolerated, and effective, despite its inferior performance to hydroquinone in decreasing mMASI and MELASQoL in the treatment of melasma.